{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:54:28Z","timestamp":1792932868625,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1053\/j.gastro.2010.10.049","type":"journal-article","created":{"date-parts":[[2010,10,31]],"date-time":"2010-10-31T04:16:53Z","timestamp":1288498613000},"page":"497-507.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":540,"title":["Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular Carcinoma"],"prefix":"10.1053","volume":"140","author":[{"given":"Riad","family":"Salem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Kulik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahsun","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K.","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent T.","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Nikolaidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank H.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Yaghmai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad M.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seanthan","family":"Senthilnathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talia","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa L.","family":"Gates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassel","family":"Atassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khairuddin","family":"Memon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Vogelzang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert A.","family":"Nemcek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Resnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard B.","family":"Chrisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reed A.","family":"Omary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Abecassis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Al B.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary F.","family":"Mulcahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2010.10.049_bib1","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1002\/hep.1840360710","article-title":"Hepatocellular carcinoma and hepatitis C in the United States","volume":"36","author":"El-Serag","year":"2002","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.10.049_bib2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2010.10.049_bib3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2010.10.049_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.gastro.2010.10.049_bib5","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1200\/JCO.2010.28.7805","article-title":"Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting","volume":"28","author":"Thomas","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.gastro.2010.10.049_bib6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.6004\/jnccn.2009.0027","article-title":"NCCN clinical practice guidelines in oncology: hepatobiliary cancers","volume":"7","author":"Benson","year":"2009","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1053\/j.gastro.2010.10.049_bib7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","article-title":"Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes","volume":"138","author":"Salem","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.10.049_bib8","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1148\/radiol.2533091286","article-title":"Comparative effectiveness research: what it means for radiology","volume":"253","author":"Pandharipande","year":"2009","journal-title":"Radiology"},{"key":"10.1053\/j.gastro.2010.10.049_bib9","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1002\/sim.3818","article-title":"Comparative effectiveness research: policy context, methods development and research infrastructure","volume":"29","author":"Tunis","year":"2010","journal-title":"Stat Med"},{"key":"10.1053\/j.gastro.2010.10.049_bib10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/hep.23819","article-title":"Efficacy, effectiveness, and comparative effectiveness in liver disease","volume":"52","author":"El-Serag","year":"2010","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.10.049_bib11","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/jama.2010.259","article-title":"Charting a path from comparative effectiveness funding to improved patient-centered health care","volume":"303","author":"Conway","year":"2010","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2010.10.049_bib12","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1148\/radiol.10091473","article-title":"Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort","volume":"255","author":"Lewandowski","year":"2010","journal-title":"Radiology"},{"key":"10.1053\/j.gastro.2010.10.049_bib13","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/jnci\/djn134","article-title":"Design and endpoints of clinical trials in hepatocellular carcinoma","volume":"100","author":"Llovet","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.gastro.2010.10.049_bib14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma","volume":"35","author":"Bruix","year":"2001","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2010.10.049_bib15","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.10.049_bib16","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1053\/j.gastro.2004.09.032","article-title":"Chemoembolization for hepatocellular carcinoma","volume":"127","author":"Bruix","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.10.049_bib17","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/01.RVI.0000233785.75257.9A","article-title":"Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 1: technical and methodologic considerations","volume":"17","author":"Salem","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.gastro.2010.10.049_bib18","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1200\/JCO.2009.23.1282","article-title":"Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival","volume":"27","author":"Riaz","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.gastro.2010.10.049_bib19","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/cncr.24050","article-title":"Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable?","volume":"115","author":"Forner","year":"2009","journal-title":"Cancer"},{"key":"10.1053\/j.gastro.2010.10.049_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.gastro.2010.10.049_bib21","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jama.2010.262","article-title":"Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma","volume":"303","author":"Riaz","year":"2010","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2010.10.049_bib22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1053\/j.gastro.2010.10.049_bib23","series-title":"Analysis of survival data","author":"Cox","year":"1984"},{"key":"10.1053\/j.gastro.2010.10.049_bib24","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1148\/radiol.2343040350","article-title":"Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation","volume":"234","author":"Lencioni","year":"2005","journal-title":"Radiology"},{"key":"10.1053\/j.gastro.2010.10.049_bib25","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2010.10.049_bib26","first-page":"1539","article-title":"The effect of doxorubicin on the changes of serum vascular endothelial growth factor (VEGF) in patients with hepatocellular carcinoma after transcatheter arterial chemoembolization (TACE)","volume":"91","author":"Leelawat","year":"2008","journal-title":"J Med Assoc Thai"},{"key":"10.1053\/j.gastro.2010.10.049_bib27","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.jvir.2008.06.017","article-title":"Comparison of hypoxia-inducible factor-1\u03b1 expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors","volume":"19","author":"Virmani","year":"2008","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.gastro.2010.10.049_bib28","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s00270-005-0171-4","article-title":"Treatment of unresectable primary and metastatic liver cancer with Yttrium-90 microspheres (TheraSphere(R)): assessment of hepatic arterial embolization","volume":"29","author":"Sato","year":"2006","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1053\/j.gastro.2010.10.049_bib29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/hep.21980","article-title":"Safety and efficacy of (90)Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis","volume":"47","author":"Kulik","year":"2007","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.10.049_bib30","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1053\/j.gastro.2004.09.034","article-title":"Yttrium-90 microspheres for the treatment of hepatocellular carcinoma","volume":"127","author":"Geschwind","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.10.049_bib31","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/j.1600-6143.2009.02695.x","article-title":"A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization","volume":"9","author":"Lewandowski","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1053\/j.gastro.2010.10.049_bib32","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJMp0901355","article-title":"Does comparative-effectiveness research threaten personalized medicine?","volume":"360","author":"Garber","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2010.10.049_bib33","first-page":"49","article-title":"Comparison of post-embolization syndrome in the treatment of patients with unresectable hepatocellular carcinoma: trans-catheter arterial chemo-embolization versus Yttrium-90 glass microspheres","volume":"3","author":"Goin","year":"2004","journal-title":"World J Nucl Med"},{"key":"10.1053\/j.gastro.2010.10.049_bib34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","article-title":"Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study","volume":"33","author":"Lammer","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1053\/j.gastro.2010.10.049_bib35","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2008.18.8151","article-title":"New utility of an old marker: serial \u03b1-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy","volume":"27","author":"Chan","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.gastro.2010.10.049_bib36","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/hep.22747","article-title":"Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres","volume":"49","author":"Riaz","year":"2009","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.10.049_bib37","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00270-009-9766-5","article-title":"Radiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolization","volume":"33","author":"Riaz","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1053\/j.gastro.2010.10.049_bib38","first-page":"559","article-title":"The problem of multiple testing and solutions for genome-wide studies","volume":"146","author":"Gyorffy","year":"2005","journal-title":"Orv Hetil"},{"key":"10.1053\/j.gastro.2010.10.049_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/157488406775268228","article-title":"Clinical trials are often false positive: a review of simple methods to control this problem","volume":"1","author":"Cleophas","year":"2006","journal-title":"Curr Clin Pharmacol"},{"key":"10.1053\/j.gastro.2010.10.049_bib40","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/sim.3960","article-title":"On the limitations of comparative effectiveness research","volume":"29","author":"Rubin","year":"2010","journal-title":"Stat Med"},{"key":"10.1053\/j.gastro.2010.10.049_bib41","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/sim.3933","article-title":"What is evidence?","volume":"29","author":"Normand","year":"2010","journal-title":"Stat Med"},{"key":"10.1053\/j.gastro.2010.10.049_bib42","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jvir.2009.10.013","article-title":"Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma","volume":"21","author":"Kooby","year":"2010","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.gastro.2010.10.049_bib43","first-page":"1683","article-title":"A retrospective comparative analysis of the effect of Y90-radioembolization on the survival of patients with unresectable hepatocellular carcinoma","volume":"56","author":"D'Avola","year":"2009","journal-title":"Hepatogastroenterology"},{"key":"10.1053\/j.gastro.2010.10.049_bib44","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/cncr.24884","article-title":"Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a Two-Cohort Study","volume":"116","author":"Carr","year":"2010","journal-title":"Cancer"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508510015878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508510015878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T14:54:41Z","timestamp":1758034481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508510015878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0016508510015878"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2010.10.049","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.6687956.6843054","asserted-by":"object"}]},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2010.10.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}